Trial Profile
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: a retrospective study(WJOG4407GSS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Oct 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 04 Sep 2020 Results published in the Medicine
- 05 Nov 2018 Status changed from active, no longer recruiting to completed.
- 08 May 2017 Status changed from recruiting to active, no longer recruiting.